Montreal-based CellCarta, formerly Caprion-HistoGeneX, has acquired Biogazelle, a Ghent, Belgium-based specialist in applications to support pharmaceutical research, clinical trials and diagnostic ...

MONTRÉAL, Aug. 31, 2021 /PRNewswire/ - CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, ...

Global contract research organization (CRO) transforms its regulatory affairs and unlocks efficiency gains and greater compliance confidence. In a move to address the growing complexity of global ...

Montreal-based CellCarta, formerly Caprion-HistoGeneX, has acquired Reveal Biosciences, a San Diego, California-based computational pathology company. No financial terms were disclosed. Reveal ...

The MarketWatch News Department was not involved in the creation of this content. Dr. El-Gabry will also lead CellCarta's global pathology organization and Medical Affairs function. MONTREAL and ...

Lunit said on the 25th that it signed a partnership with Canada's CellCarta to use the artificial intelligence (AI) biomarker platform "Lunit Scope" in clinical trials. CellCarta is a global contract ...

This acquisition solidifies CellCarta's leadership position in genomic services with a unique combination of assay development and global clinical trial sample analysis capabilities covering a ...

MONTREAL, May 27, 2026 /PRNewswire/ -- CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a Strategic Partnership with Sonic Healthcare USA, Inc. ("SHUAS" or ...

The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, England and MONTREAL, March 19, 2026 /PRNewswire/ -- CellCarta and Biofidelity today announce an expanded ...

Global contract research organization (CRO) transforms its regulatory affairs and unlocks efficiency gains and greater compliance confidence. NEW YORK & SINGAPORE, April 21, 2026--(BUSINESS WIRE)--In ...